Synopsys

Synopsys Securities Fraud Class Action Lawsuit: Investors Urged to Contact BFA Law by December 30 Deadline.

新思科技

Faruqi & Faruqi Investigating Synopsys Securities Class Action Suit.

Synopsys Class Action Lawsuit Filed Over Alleged Securities Violations

Synopsys Investors Have Until Dec 30 to File Lead Plaintiff Applications.

aTyr Pharma

Synopsys investors sue for alleged false and misleading statements.

Catalyst<ul> <li>Multiple WR Overbought signals in late November and early December suggest a bullish bias for SNPS.</li> <li>Analysts rate SNPS with a mix of Buy, Neutral, and Strong Buy, showing varied but generally optimistic institutional views.</li> <li>Fundamental factors such as strong ROA, gross profit margin, and cash reserves relative to market value indicate solid profitability and financial health.</li></ul>Risk<ul> <li>Fund flow data shows that medium and large orders are trending negatively, indicating possible outflows from larger investors.</li> <li>Technical indicators remain neutral with mixed signals, suggesting market uncertainty and lack of a clear trend for SNPS.</li></ul>

Key Factors

Nvidia invests $2 billion in Synopsys, forming a multiyear partnership to integrate AI and GPU technologies into Synopsys' engineering software.A securities fraud class action lawsuit is filed against Synopsys, alleging false and misleading statements made to investors between December 4, 2024, and September 9, 2025.Keybanc maintains an Overweight rating for Synopsys but lowers its price target to $575.

Recent Updates

SNPS News